Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,660 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiac-specific activation of angiotensin II type 1 receptor-associated protein completely suppresses cardiac hypertrophy in chronic angiotensin II-infused mice.
Wakui H, Tamura K, Tanaka Y, Matsuda M, Bai Y, Dejima T, Masuda S, Shigenaga A, Maeda A, Mogi M, Ichihara N, Kobayashi Y, Hirawa N, Ishigami T, Toya Y, Yabana M, Horiuchi M, Minamisawa S, Umemura S. Wakui H, et al. Among authors: maeda a. Hypertension. 2010 May;55(5):1157-64. doi: 10.1161/HYPERTENSIONAHA.109.147207. Epub 2010 Mar 15. Hypertension. 2010. PMID: 20231526
Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
Dejima T, Tamura K, Wakui H, Maeda A, Ohsawa M, Kanaoka T, Haku S, Kengo A, Masuda S, Shigenaga A, Azuma K, Matsuda M, Yabana M, Hirose T, Uchino K, Kimura K, Nagashima Y, Umemura S. Dejima T, et al. Among authors: maeda a. J Hypertens. 2011 Oct;29(10):1919-29. doi: 10.1097/HJH.0b013e32834a5a46. J Hypertens. 2011. PMID: 21844822
Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
Maeda A, Tamura K, Kanaoka T, Ohsawa M, Haku S, Azushima K, Dejima T, Wakui H, Yanagi M, Okano Y, Fujikawa T, Toya Y, Mizushima S, Tochikubo O, Umemura S. Maeda A, et al. Clin Exp Hypertens. 2012;34(4):249-57. doi: 10.3109/10641963.2012.681081. Epub 2012 May 9. Clin Exp Hypertens. 2012. PMID: 22571446 Clinical Trial.
The physiology and pathophysiology of a novel angiotensin receptor-binding protein ATRAP/Agtrap.
Tamura K, Wakui H, Maeda A, Dejima T, Ohsawa M, Azushima K, Kanaoka T, Haku S, Uneda K, Masuda S, Azuma K, Shigenaga A, Koide Y, Tsurumi-Ikeya Y, Matsuda M, Toya Y, Tokita Y, Yamashita A, Umemura S. Tamura K, et al. Among authors: maeda a. Curr Pharm Des. 2013;19(17):3043-8. doi: 10.2174/1381612811319170010. Curr Pharm Des. 2013. PMID: 23176217 Review.
Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension.
Wakui H, Tamura K, Masuda S, Tsurumi-Ikeya Y, Fujita M, Maeda A, Ohsawa M, Azushima K, Uneda K, Matsuda M, Kitamura K, Uchida S, Toya Y, Kobori H, Nagahama K, Yamashita A, Umemura S. Wakui H, et al. Among authors: maeda a. Hypertension. 2013 Jun;61(6):1203-10. doi: 10.1161/HYPERTENSIONAHA.111.00572. Epub 2013 Mar 25. Hypertension. 2013. PMID: 23529167 Free PMC article.
Addition of aliskiren to Angiotensin receptor blocker improves ambulatory blood pressure profile and cardiorenal function better than addition of benazepril in chronic kidney disease.
Ohsawa M, Tamura K, Kanaoka T, Wakui H, Maeda A, Dejima T, Azushima K, Uneda K, Kobayashi R, Tsurumi-Ikeya Y, Toya Y, Fujikawa T, Umemura S. Ohsawa M, et al. Among authors: maeda a. Int J Mol Sci. 2013 Jul 24;14(8):15361-75. doi: 10.3390/ijms140815361. Int J Mol Sci. 2013. PMID: 23887656 Free PMC article. Clinical Trial.
1,660 results